.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Argus Health
McKesson
QuintilesIMS
Novartis
Healthtrust
UBS
Federal Trade Commission
Chubb
Deloitte

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204730

« Back to Dashboard

NDA 204730 describes FROVATRIPTAN SUCCINATE, which is a drug marketed by Glenmark Pharms Ltd and Mylan Pharms Inc and is included in two NDAs. It is available from two suppliers. Additional details are available on the FROVATRIPTAN SUCCINATE profile page.

The generic ingredient in FROVATRIPTAN SUCCINATE is frovatriptan succinate. There are three drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the frovatriptan succinate profile page.

Summary for 204730

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antimigraine Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 204730

Suppliers and Packaging for NDA: 204730

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 204730 ANDA Glenmark Pharmaceuticals Inc., USA 68462-694 68462-694-97 1 BLISTER PACK in 1 CARTON (68462-694-97) > 9 TABLET, FILM COATED in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 2.5MG BASE
Approval Date:Mar 11, 2016TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Moodys
Accenture
Argus Health
Fuji
Cipla
Colorcon
Cantor Fitzgerald
McKesson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot